Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
GH Secretagogues 3 min read

MK-677 (Ibutamoren): Non-Peptide Ghrelin Receptor (GHSR-1a) Agonism, Pulsatile GH Kinetics, and IGF-1 Assays

Compiled & reviewed by SwissLab Bioenergetics & Compliance Desk — Cellular Bioenergetics, Neuropeptides & RUO Governance Desk
Editorial Standards
Analytical Summary

A pharmacological evaluation of MK-677 (Ibutamoren Mesylate). GHSR-1a selectivity, pulsatile growth hormone secretion vs tonic elevation, IGF-1 elevation kinetics, and laboratory handling. MK-677 is an orally bioavailable, non-peptide spiroindoline agonist of the growth hormone secretagogue receptor 1a (GHSR-1a).

Key Research Takeaways
  • MK-677 is an orally bioavailable, non-peptide spiroindoline agonist of the growth hormone secretagogue receptor 1a (GHSR-1a).
  • Binds GHSR-1a with high affinity (Ki = 0.4 nM), mimicking endogenous ghrelin to stimulate pulsatile pituitary GH release.
  • Increases serum IGF-1 and IGFBP-3 concentrations without depleting pituitary GH stores or disrupting physiological pulsatility.
  • Soluble in DMSO and ethanol; supplied as a stable mesylate salt for in-vitro endocrine and cellular metabolism research.
Analytical & Handling Reference Matrix
CAS Registry Number 159752-10-0
Molecular Formula C27H36N4O5S·CH4O3S
Molecular Mass 624.77 g/mol
Primary Biological Target Growth Hormone Secretagogue Receptor 1a (GHSR-1a, Ki = 0.4 nM)
Analytical Purity Standard ≥99.0% (RP-HPLC, C18, 214/220 nm)
Identity Verification ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%)
Lyophilized Storage -20°C desiccated, protected from UV light (24–36 months)
Reconstituted Storage 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water)

1. Chemical Class and GHSR-1a Receptor Binding

MK-677 (Ibutamoren Mesylate, L-163,191) is a synthetic non-peptide spiroindoline derivative: 2-amino-N-[2-(benzyloxy)-1-(1-methylsulfonylspiro[2H-indene-3,4'-piperidine]-1'-yl)-1-oxoethyl]-2-methylpropanamide methanesulfonate. It acts as a highly potent, selective agonist of the Ghrelin/Growth Hormone Secretagogue Receptor (GHSR-1a) with a dissociation constant (Ki) of 0.4 nM, showing greater than 1000-fold selectivity over other G-protein coupled receptors.

2. Pulsatile Pituitary Release vs Continuous Overexpression

Unlike exogenous recombinant somatropin (rhGH) administration, which produces a flat, non-physiological elevated GH plateau that downregulates peripheral receptors, MK-677 amplifies natural endogenous pulsatile GH secretion from anterior pituitary somatotroph cells. MK-677 acts synergistically with hypothalamic GHRH while antagonizing somatostatin (SRIF) inhibitory tone.

3. Serum IGF-1 Modulation and Nitrogen Balance

In metabolic research models, GHSR-1a activation by MK-677 leads to sustained elevations in circulating IGF-1 concentrations by 60% to 100% within 14 days, accompanied by parallel increases in IGF-binding protein 3 (IGFBP-3). Importantly, cortisol and prolactin levels show only modest, transient elevations during initial exposure before returning to baseline, preserving endocrine specificity.

4. Laboratory Solubility and Reconstitution

MK-677 mesylate is a white-to-off-white crystalline powder with high solubility in polar organic solvents: DMSO (>25 mg/mL) and anhydrous ethanol (>10 mg/mL), and moderate solubility in water. In-vitro research stocks are typically prepared in 100% DMSO and diluted into aqueous culture media immediately prior to application. Solid stocks remain stable at 20°C to 25°C desiccated for over 24 months.

5. Small-Molecule Stock Preparation & Quantitative Assay Controls

Because MK-677 (Ibutamoren) is a non-peptide small molecule or coenzyme (C27H36N4O5S·CH4O3S, MW 624.77 g/mol), molar stock calculations should reference the exact formula weight—including any halide or buffer counterion—rather than polypeptide Net Peptide Content estimates. Keep final organic co-solvent (such as DMSO) below 0.5%–1.0% v/v in cellular assays and include matched vehicle controls.

Peer-Reviewed References & Analytical Standards

  1. Patchett A.A. et al. (1995). Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences, 92(15), 7001–7005. [PMID: 7624358 ↗]
  2. Chapman I.M. et al. (1996). Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab, 81(12), 4249–4257. [PMID: 8954023 ↗]

Referenced Laboratory Research Reagents

Batch-verified SwissLab catalog entries cited in this monograph

All 66 Compounds →
Laboratory Compliance & Handling Protocol

All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.

Related Research Monographs

All monographs (44)

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog